ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere

NCT00043576 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

250

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: calcitriol
DRUG: docetaxel

Sponsor

Novacea

Collaborators

[object Object]